Growth media for cultivated meat: what the medium does
Growth media for cultivated meat supply everything that animal cells need while they multiply in a bioreactor. The basal part contains amino acids, glucose, vitamins and salts. A second part holds proteins that signal cells to divide and differentiate, such as growth factors, insulin and transferrin, plus carriers such as albumin.
Historically the signaling part came from fetal bovine serum. Serum is variable, expensive and carries ethical objections, so cultivated meat developers moved to serum-free media. A scoping review in a peer-reviewed journal describes serum-free formulations as the target for the industry but notes they are still less efficient than serum in many cell types,.
The topic matters beyond biology because media are the largest cost block. A 2024 review reports that serum-free medium makes up at least 50 percent of variable operating costs in cultivated meat manufacturing, mainly through growth factors and recombinant proteins. Any plan for making cultivated meat affordable therefore starts with the medium recipe and where each component comes from.
Serum-free formulations and growth factors
Published serum-free recipes differ greatly in price. In the 2024 review’s laboratory analysis, total cost per litre ran from about 454 to 5,678 Singapore dollars across formulations taken from the literature. The spread tracks the proteins: in one formulation growth factors and recombinant proteins made up 91.3 percent of cost, and in another only 9.1 percent.
Two named media show the concentration of cost. In Essential 8, nearly 98 percent of the cost can be attributed to FGF-2 and TGF-beta. In Beefy-9, a medium designed for bovine cells, albumin, FGF-2 and insulin together make up around 60 percent. FGF-2 is the growth factor most often used, and insulin and transferrin are common additives.
Cost therefore depends on how much protein is needed and how stable it is. The thermostable FGF2-G3 mutant, for example, has a half-life that rises from 10 hours to 20 days, which could cut how often medium must be changed. Albumin is needed at milligrams per millilitre, far above growth factors, so its price per gram matters.
Growth media for cultivated meat in techno-economic analysis
Techno-economic work puts numbers on this. In Humbird’s 2021 analysis, amino acids in the medium cost 19 dollars per kilogram of wet cell mass in a fed-batch process, and growth factors 3 dollars, out of total production costs of 37 dollars per kilogram. The author set a price-parity target of about 25 dollars per kilogram of bulk cell mass.
Hydrolysates change that picture on paper. Humbird estimated that substituting plant hydrolysate at 2 dollars per kilogram of mixed amino acids would cut the amino acid contribution by almost 16 dollars per kilogram, taking the fed-batch cost to 22 dollars per kilogram. The analysis called metabolic efficiency and low-cost hydrolysate media necessary but insufficient conditions for affordability.
Later reviews qualify the hydrolysate route. They flag batch variability and contaminant risk when complex plant digests are used. Cost per litre is also an incomplete metric; yield per litre matters at least as much. A cheaper medium that supports lower density can leave cost per kilogram of cells unchanged.
Recombinant growth factors and the supply chain
Because growth factors dominate costs, their supply chain is a focus. In December 2021 WACKER and Aleph Farms announced an open supply chain for growth-medium proteins. The release says these proteins are not widely available and are among the largest cost drivers, and that WACKER develops fermentation techniques in Munich to make them for food use, free of animal ingredients.
The agreement is non-exclusive, so any cultivated meat company can obtain the proteins. The partners state a goal of reducing protein costs significantly by matching food-industry standards for quality and scale, and they expect that to help the industry reach price parity sooner. Actual price effects will depend on volumes, contract terms and the growth-medium formulation each producer adopts.
In November 2025 WACKER announced a food-grade recombinant bovine FGF-basic product, FGF-2 Food. The release describes it as made by fermentation, highly purified and free of animal-derived components, and states that earlier supplies were pharmaceutical grade in small quantities. Deliveries were to start in late 2025, first in the United States, with Asia and Europe following.
Cheaper growth factors and cell engineering
Several technical routes aim to shrink the growth factor bill. Bacterial production is one: a study cited in the 2024 review produced growth factors in E. coli and cut the growth factor share of Essential 8 cost from 86 percent to 2 percent. Another group reached 55 milligrams per litre of recombinant bovine FGF1 in E. coli.
Plants and cell-free systems offer alternatives. The review reports a molecular farming company that expects plant-made proteins at about 1 dollar per gram, and a cell-free platform that can yield about 3 grams per litre. Such claims come from the developers and apply to specific proteins, so food-grade purity, regulatory clearance and real prices at tonnage still need proof.
A different approach engineers the cells. Researchers engineered bovine satellite cells to express FGF2 themselves, reaching a 60-hour doubling time against 55 hours with added recombinant FGF. The authors of the review caution that this approach may not suit albumin, which is needed at much higher quantities, so cell engineering and bought-in proteins are likely to coexist.
Food-grade inputs and media recycling
Basal medium cost can fall by switching from laboratory reagents to food-grade ingredients. The 2024 review reports that food-grade components average 17.9 percent of reagent-grade prices at 1 kilogram scale, about 82 percent cheaper, and cites an estimate that bulk food-grade equivalents could reduce basal medium cost by 77 percent.
Recycling is the other lever. Believer Meats was described as the only cultivated meat company to implement spent medium recycling in production, before it ceased operations in December 2025. A hybridoma study saved 67 percent of complete medium, yet another team found that mainly water was saved, with little material cost benefit, so results differ by culture system.
Some companies report very low media prices. Believer Meats reported a serum-free medium at 0.63 dollars per litre by replacing albumin and optimising component concentrations, according to the review. Such figures come from company statements and describe medium price, not the cost of a kilogram of finished meat, which also includes bioreactors, energy, labour and downstream steps.
Precision fermentation and the medium
Precision fermentation sits at the centre of the medium story. A peer-reviewed critique notes that serum-free media cost more than serum because of recombinant growth factors, and that precision fermentation is needed to make those growth factors. Cultivated meat therefore depends on the same microbial capacity that dairy and egg proteins use, which can compete for scarce vessels.
Product type changes the demand. Cultivated beef and cultivated chicken use different cells with different needs, and cultivated fat grows adipocytes that need their own differentiation signals. A medium tuned for fast myoblast growth may not suit fat cells, so there will not be one universal recipe, and costs will differ by cell type.
What has to change for lower media costs
Taken together, the sources point to four moves: cheaper or self-produced growth factors, food-grade basal components, higher cell density and longer-lived proteins, and recycling of used medium. None alone is enough. Humbird called low-cost media necessary but insufficient, and reviews place the medium alongside capital cost and metabolic efficiency as conditions for price parity.
Claims should be checked by what they measure. Price per litre of medium, share of operating cost, price per gram of a growth factor and cost per kilogram of cells are different quantities. A partnership that promises lower protein prices is a direction of travel, not a measured reduction, until a food-grade price list is published.
The practical conclusion for product developers is modest. Growth media for cultivated meat are becoming cheaper on paper, with several credible routes, but published evidence of large cost reductions at industrial scale is thin. Any business case should state its medium assumptions explicitly, show the sensitivity to growth factor price, and separate lab prices from food-grade offers.